171 related articles for article (PubMed ID: 37807805)
1. Macrophage-Derived Extracellular Vesicles-Coated Palladium Nanoformulations Modulate Inflammatory and Immune Homeostasis for Targeting Therapy of Ulcerative Colitis.
Cheng J; Zhang Y; Ma L; Du W; Zhang Q; Gao R; Zhao X; Chen Y; Jiang L; Li X; Li B; Zhou Y
Adv Sci (Weinh); 2023 Nov; 10(33):e2304002. PubMed ID: 37807805
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
3.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
4. Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1/M2 Macrophage Balance
Zhuang H; Lv Q; Zhong C; Cui Y; He L; Zhang C; Yu J
Front Immunol; 2021; 12():649463. PubMed ID: 33868286
[TBL] [Abstract][Full Text] [Related]
5. Restoration of dysregulated intestinal barrier and inflammatory regulation through synergistically ameliorating hypoxia and scavenging reactive oxygen species using ceria nanozymes in ulcerative colitis.
Zhang Y; Lei H; Wang P; Zhou Q; Yu J; Leng X; Ma R; Wang D; Dong K; Xing J; Dong Y
Biomater Res; 2023 Jul; 27(1):75. PubMed ID: 37507801
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-based nanotherapeutic strategies in ulcerative colitis.
Zhang J; Zhao Y; Hou T; Zeng H; Kalambhe D; Wang B; Shen X; Huang Y
J Control Release; 2020 Apr; 320():363-380. PubMed ID: 32001299
[TBL] [Abstract][Full Text] [Related]
7. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization.
Wu MM; Wang QM; Huang BY; Mai CT; Wang CL; Wang TT; Zhang XJ
Pharmacol Res; 2021 Oct; 172():105796. PubMed ID: 34343656
[TBL] [Abstract][Full Text] [Related]
8. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
[TBL] [Abstract][Full Text] [Related]
9. Quercetin serves as the major component of Xiang-lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1/PPARĪ³ and dictating the alternative activation of macrophage.
Zhou HF; Yang C; Li JY; He YY; Huang Y; Qin RJ; Zhou QL; Sun F; Hu DS; Yang J
J Ethnopharmacol; 2023 Sep; 313():116557. PubMed ID: 37142141
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance.
Yu T; Chu S; Liu X; Li J; Chen Q; Xu M; Wu H; Li M; Dong Y; Zhu F; Zhou H; Hu D; Fan H
Stem Cell Res Ther; 2021 Mar; 12(1):181. PubMed ID: 33722292
[TBL] [Abstract][Full Text] [Related]
11. Rab27A promotes cellular apoptosis and ROS production by regulating the miRNA-124-3p/STAT3/RelA signalling pathway in ulcerative colitis.
Luo Y; Yu MH; Yan YR; Zhou Y; Qin SL; Huang YZ; Qin J; Zhong M
J Cell Mol Med; 2020 Oct; 24(19):11330-11342. PubMed ID: 32815642
[TBL] [Abstract][Full Text] [Related]
12. Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy.
Sun Q; Chen J; Zhao Q; He Z; Tang L; Pu Y; He B
Int J Pharm; 2023 May; 639():122962. PubMed ID: 37068716
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.
Ma Y; Gao W; Zhang Y; Yang M; Yan X; Zhang Y; Li G; Liu C; Xu C; Zhang M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6358-6369. PubMed ID: 35099925
[TBL] [Abstract][Full Text] [Related]
14. Injectable Bioadhesive Hydrogels Scavenging ROS and Restoring Mucosal Barrier for Enhanced Ulcerative Colitis Therapy.
Li D; Li J; Chen T; Qin X; Pan L; Lin X; Liang W; Wang Q
ACS Appl Mater Interfaces; 2023 Aug; 15(32):38273-38284. PubMed ID: 37530040
[TBL] [Abstract][Full Text] [Related]
15. Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis.
Luo R; Liu J; Cheng Q; Shionoya M; Gao C; Wang R
Sci Adv; 2024 Jun; 10(26):eado6798. PubMed ID: 38941458
[TBL] [Abstract][Full Text] [Related]
16. Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis.
Wan Y; Yang L; Jiang S; Qian D; Duan J
Inflamm Bowel Dis; 2022 Mar; 28(4):639-648. PubMed ID: 34871402
[TBL] [Abstract][Full Text] [Related]
17. Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota.
Liang L; Yang C; Liu L; Mai G; Li H; Wu L; Jin M; Chen Y
Microb Cell Fact; 2022 May; 21(1):88. PubMed ID: 35578339
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization.
Cao L; Xu H; Wang G; Liu M; Tian D; Yuan Z
Int Immunopharmacol; 2019 Jul; 72():264-274. PubMed ID: 31005036
[TBL] [Abstract][Full Text] [Related]
19. A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals.
Wang K; Mao T; Lu X; Wang M; Yun Y; Jia Z; Shi L; Jiang H; Li J; Shi R
Front Immunol; 2023; 14():1155077. PubMed ID: 37197668
[TBL] [Abstract][Full Text] [Related]
20. A Biomimetic Nanoplatform with Improved Inflammatory Targeting Behavior for ROS Scavenging-Based Treatment of Ulcerative Colitis.
Wang X; Jiao M; Tian F; Lu X; Xiong H; Liu F; Wan Y; Zhang X; Wan H
Adv Healthc Mater; 2023 Nov; 12(29):e2301450. PubMed ID: 37537878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
